Lun‐Xiu Qin

5.6k total citations · 5 hit papers
20 papers, 4.1k citations indexed

About

Lun‐Xiu Qin is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Lun‐Xiu Qin has authored 20 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Hepatology. Recurrent topics in Lun‐Xiu Qin's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Lun‐Xiu Qin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Lun‐Xiu Qin collaborates with scholars based in China, United States and France. Lun‐Xiu Qin's co-authors include Xin Wei Wang, Marshonna Forgues, Zhao-You Tang, Anuradha Budhu, Yidong Chen, Ping He, Stéphanie Roessler, Ju‐Seog Lee, Snorri S. Thorgeirsson and Carlo M. Croce and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Hepatology.

In The Last Decade

Lun‐Xiu Qin

20 papers receiving 4.0k citations

Hit Papers

A Unique Metastasis Gene Signature Enables Prediction of ... 2003 2026 2010 2018 2010 2003 2006 2009 2019 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
    2010 757 citations Stéphanie Roessler, Anuradha Budhu et al. Cancer Research profile →
  2. Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
    2003 679 citations Lun‐Xiu Qin, Marshonna Forgues et al. Nature Medicine profile →
  3. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
    2006 662 citations Anuradha Budhu, Marshonna Forgues et al. Cancer Cell profile →
  4. MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer
    2009 639 citations Junfang Ji, Jiong Shi et al. New England Journal of Medicine profile →
  5. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade
    2019 333 citations Ying Zhu, Jing Yang et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lun‐Xiu Qin China 17 2.3k 1.8k 974 783 652 20 4.1k
Zhao-You Tang China 13 1.9k 0.8× 1.5k 0.8× 796 0.8× 677 0.9× 443 0.7× 13 3.3k
Amaia Lujambio United States 27 4.2k 1.9× 2.8k 1.5× 1.2k 1.3× 536 0.7× 764 1.2× 54 6.1k
Stéphanie Roessler Germany 33 2.8k 1.2× 2.2k 1.2× 1.1k 1.1× 588 0.8× 501 0.8× 89 4.7k
Xiaowu Huang China 35 2.2k 1.0× 1.7k 0.9× 1.5k 1.6× 973 1.2× 1.2k 1.9× 112 4.8k
ST Cheung Hong Kong 38 2.7k 1.2× 1.2k 0.7× 1.6k 1.6× 929 1.2× 443 0.7× 86 4.9k
Junfang Ji China 25 3.1k 1.4× 2.4k 1.3× 1.3k 1.3× 781 1.0× 348 0.5× 55 4.9k
Zhen‐Bin Ding China 36 1.9k 0.8× 1.1k 0.6× 1.3k 1.3× 570 0.7× 806 1.2× 89 4.1k
Roberta Pang Hong Kong 29 1.6k 0.7× 987 0.5× 1.1k 1.1× 815 1.0× 278 0.4× 53 3.0k
Ai‐Wu Ke China 41 3.7k 1.6× 2.2k 1.2× 1.4k 1.4× 563 0.7× 950 1.5× 93 5.9k
David S. Rickman United States 34 2.8k 1.2× 1.6k 0.9× 1.4k 1.4× 669 0.9× 496 0.8× 63 5.6k

Countries citing papers authored by Lun‐Xiu Qin

Since Specialization
Citations

This map shows the geographic impact of Lun‐Xiu Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lun‐Xiu Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lun‐Xiu Qin more than expected).

Fields of papers citing papers by Lun‐Xiu Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lun‐Xiu Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lun‐Xiu Qin. The network helps show where Lun‐Xiu Qin may publish in the future.

Co-authorship network of co-authors of Lun‐Xiu Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Lun‐Xiu Qin. A scholar is included among the top collaborators of Lun‐Xiu Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lun‐Xiu Qin. Lun‐Xiu Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Ran, Wenwei Zhu, Xuan Wang, et al.. (2020). S100 calcium‐binding protein A9 from tumor‐associated macrophage enhances cancer stem cell‐like properties of hepatocellular carcinoma. International Journal of Cancer. 148(5). 1233–1244. 60 indexed citations
2.
Zhang, Yu, et al.. (2019). Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy. Cell Biology and Toxicology. 35(5). 407–421. 50 indexed citations
3.
Zhu, Ying, Jing Yang, Da Xu, et al.. (2019). Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. Gut. 68(9). 1653–1666. 333 indexed citations breakdown →
4.
5.
Qin, Lun‐Xiu, et al.. (2018). [Efficacy and safety of licartin with repeated administration in treatment of HCC patients after liver transplantation].. PubMed. 98(33). 2645–2649. 1 indexed citations
6.
Li, Yan, Huaqing Wang, Lun‐Xiu Qin, et al.. (2016). Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. World Journal of Gastroenterology. 22(30). 6906–6906. 63 indexed citations
7.
Li, Tao, Lun‐Xiu Qin, Xiao Gong, et al.. (2012). Hepatitis B virus surface antigen‐negative and hepatitis C virus antibody‐negative hepatocellular carcinoma. Cancer. 119(1). 126–135. 49 indexed citations
8.
Zhao, Yiming, Lu Wang, Zhi Dai, et al.. (2011). Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma. International Journal of Cancer. 129(10). 2463–2472. 36 indexed citations
9.
Dai, Chun, Qiongzhu Dong, Ning Ren, et al.. (2011). Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinoma. Cancer Science. 102(3). 583–590. 3 indexed citations
10.
Roessler, Stéphanie, Anuradha Budhu, Marshonna Forgues, et al.. (2010). A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients. Cancer Research. 70(24). 10202–10212. 757 indexed citations breakdown →
11.
Zhang, Ti, Hui‐Chuan Sun, Peng Wang, et al.. (2009). Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells. Cancer Letters. 290(2). 204–210. 22 indexed citations
12.
Ji, Junfang, Taro Yamashita, Anuradha Budhu, et al.. (2009). Identification of microRNA‐181 by genome‐wide screening as a critical player in EpCAM–positive hepatic cancer stem cells†. Hepatology. 50(2). 472–480. 436 indexed citations
13.
Ji, Junfang, Jiong Shi, Anuradha Budhu, et al.. (2009). MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer. New England Journal of Medicine. 361(15). 1437–1447. 639 indexed citations breakdown →
14.
Pineau, Pascal, Agnès Marchio, Carlo Battiston, et al.. (2008). Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 653(1-2). 6–13. 42 indexed citations
15.
Zhuang, Peng–Yuan, Xiao‐Dong Zhu, Wei Zhang, et al.. (2008). Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor. Cancer. 112(12). 2740–2748. 56 indexed citations
16.
Budhu, Anuradha, Marshonna Forgues, Ping He, et al.. (2006). Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell. 10(2). 99–111. 662 indexed citations breakdown →
17.
Qin, Lun‐Xiu, Marshonna Forgues, Ping He, et al.. (2003). Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nature Medicine. 9(4). 416–423. 679 indexed citations breakdown →
18.
Sham, Jonathan S. T., Terence Tang, Yan Fang, et al.. (2002). Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women. Cancer Genetics and Cytogenetics. 133(1). 39–44. 45 indexed citations
19.
Qin, Lun‐Xiu, Zhao–You Tang, Jonathan S. T. Sham, et al.. (1999). The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma.. PubMed. 59(22). 5662–5. 101 indexed citations
20.
Qin, Lun‐Xiu, Luc Richard, Claudette Perennes, Pierre Gadal, & Catherine Bergounioux. (1995). Identification of a Cell Cycle-Related Gene, Cyclin, in Nicotiana tabacum (L.). PLANT PHYSIOLOGY. 108(1). 425–426. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhao-You Tang Breakdown of academic impact, for papers by Amaia Lujambio Breakdown of academic impact, for papers by Stéphanie Roessler Breakdown of academic impact, for papers by Xiaowu Huang Breakdown of academic impact, for papers by ST Cheung Breakdown of academic impact, for papers by Junfang Ji Breakdown of academic impact, for papers by Zhen‐Bin Ding Breakdown of academic impact, for papers by Roberta Pang Breakdown of academic impact, for papers by Ai‐Wu Ke Breakdown of academic impact, for papers by David S. Rickman
Rankless by CCL
2026